Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bora Pharmaceuticals is a premier global Contract Development and Manufacturing Organization (CDMO) specializing in a wide range of dosage forms, including complex oral solids, liquids, and semi-solids. The company provides end-to-end services from formulation development and clinical trial supply to large-scale commercial manufacturing and global packaging. With a significant presence in Taiwan and North America, Bora has expanded its capabilities into biologics and macromolecules through strategic acquisitions like Eden Biologics and Upsher-Smith Laboratories. As a publicly traded entity on the Taiwan Stock Exchange, Bora serves a global client base that includes major pharmaceutical companies and emerging biotech firms. The company is currently the largest pharmaceutical manufacturer in Taiwan by volume and export capacity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bora Pharmaceutical Services.